Renzi P - Search Results

1

Novel targeted therapies for eosinophilic disorders.

Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J, Prussin C, Renzi P, Rothenberg ME, Roufosse F, Simon D, Simon HU, Wardlaw A, Weller PF, Klion AD. Wechsler ME, et al. Among authors: renzi p. J Allergy Clin Immunol. 2012 Sep;130(3):563-71. doi: 10.1016/j.jaci.2012.07.027. J Allergy Clin Immunol. 2012. PMID: 22935585 Free PMC article. Review.

2

Dose-response effects of TPI ASM8 in asthmatics after allergen.

Gauvreau GM, Pageau R, Séguin R, Carballo D, Gauthier J, D'Anjou H, Campbell H, Watson R, Mistry M, Parry-Billings M, Killian K, Renzi PM. Gauvreau GM, et al. Among authors: renzi pm. Allergy. 2011 Sep;66(9):1242-8. doi: 10.1111/j.1398-9995.2011.02638.x. Epub 2011 May 24. Allergy. 2011. PMID: 21605124 Clinical Trial.

3

Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.

Gauvreau GM, Boulet LP, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K, Duong M, Watson RM, Renzi PM, O'Byrne PM. Gauvreau GM, et al. Am J Respir Crit Care Med. 2008 May 1;177(9):952-8. doi: 10.1164/rccm.200708-1251OC. Epub 2008 Jan 31. Am J Respir Crit Care Med. 2008. PMID: 18244953 Clinical Trial.

4

Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.

Renzi PM, Howard LA, Ortega HG, Ahmad FF, Chapman KR. Renzi PM, et al. Respir Med. 2010 Apr;104(4):510-7. doi: 10.1016/j.rmed.2009.10.025. Epub 2009 Nov 26. Respir Med. 2010. PMID: 19944581 Free article. Clinical Trial.

5

Safety, pharmacodynamics and pharmacokinetics of TPI 1020 in smokers with asthma.

Boulet LP, Lemière C, Gauvreau G, Olivenstein R, Lougheed D, Paradis B, O'Byrne P, Pageau R, Renzi PM. Boulet LP, et al. Among authors: renzi pm. Respir Med. 2009 Aug;103(8):1159-66. doi: 10.1016/j.rmed.2009.02.011. Epub 2009 Mar 16. Respir Med. 2009. PMID: 19286361 Free article. Clinical Trial.

6

Interleukin-2 and lymphocyte-induced eosinophil proliferation and survival in asthmatic patients.

Yang JP, Renzi PM. Yang JP, et al. Among authors: renzi pm. J Allergy Clin Immunol. 1993 Mar;91(3):792-801. doi: 10.1016/0091-6749(93)90199-p. J Allergy Clin Immunol. 1993. PMID: 8454801

7

Oligonucleotides: a multi-targeted approach for the treatment of respiratory diseases.

Ferrari N, Seguin R, Renzi P. Ferrari N, et al. Among authors: renzi p. Future Med Chem. 2011 Oct;3(13):1647-62. doi: 10.4155/fmc.11.108. Future Med Chem. 2011. PMID: 21942254 Review.

8

Inhibition of antigen-induced eosinophilia and airway hyperresponsiveness by antisense oligonucleotides directed against the common beta chain of IL-3, IL-5, GM-CSF receptors in a rat model of allergic asthma.

Allakhverdi Z, Allam M, Renzi PM. Allakhverdi Z, et al. Am J Respir Crit Care Med. 2002 Apr 1;165(7):1015-21. doi: 10.1164/ajrccm.165.7.2109095. Am J Respir Crit Care Med. 2002. PMID: 11934731

9

Interleukin-2-induced increased airway responsiveness and lung Th2 cytokine expression occur after antigen challenge through the leukotriene pathway.

Nag S, Lamkhioued B, Renzi PM. Nag S, et al. Am J Respir Crit Care Med. 2002 Jun 1;165(11):1540-5. doi: 10.1164/rccm.2109012. Am J Respir Crit Care Med. 2002. PMID: 12045130

10

The link between allergic rhinitis and asthma: a role for antileukotrienes?

Kim H, Bouchard J, Renzi PM. Kim H, et al. Among authors: renzi pm. Can Respir J. 2008 Mar;15(2):91-8. doi: 10.1155/2008/416095. Can Respir J. 2008. PMID: 18354749 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters